A major breakthrough in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This crucial malignant suppressor protein is frequently inactivated in many types of malignancies, causing https://bookmarkjourney.com/story21951591/mini-antibodies-restore-the-p53-protein-a-new-hope-for-malignant-therapy